miR-660-5p protects CML LSCs by binding the 3′ UTR of endothelial PAS domain protein 1 (EPAS1), mitigating its function in regulating cellular responses to hypoxic environments [67]. The gene discussed is EPAS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.